12:00 AM
 | 
Aug 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

Human Genome Sciences, GlaxoSmithKline deal

GlaxoSmithKline completed its acquisition of Human Genome for $14.25 per share in cash, or about $3 billion. Following the initial close of the pharma's tender offer on July 30,...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >